http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2008105663-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-366
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-165
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-166
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-165
filingDate 2006-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2009-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber RU-2008105663-A
titleOfInvention CANCER TREATMENT METHOD (OPTIONS)
abstract 1. A method of treating cancer, comprising administering to a subject in need thereof an effective amount of a composition containing a compound of formula (Ia)! ! where R1, R2, R3, R4 and R5 are independently selected from the group consisting of: hydrogen, hydroxy, amino, nitro, iodo, bromo, fluoro, chloro (C1-C6) alkyl , (C1-C6) alkoxy, (C3-C7) cycloalkyl, and phenyl, with at least two of the five R1, R2, R3, R4 and R5 substituents always representing hydrogen, at least one of the five substituents represents a nitro group, at least one of the substituents attached to the nitro group, represents iodine; as well as its pharmaceutically available salts, solvates, isomers, tautomers, metabolites, analogues or prodrugs! the method is intended for the treatment of cancers such as ovarian cancer, endometrial cancer, cervical cancer, pancreatic cancer, gall bladder cancer, eye cancer, central nervous system cancer, kidney cancer, thyroid cancer and lung cancer. ! 2. A method of treating cancer, comprising administering to a subject in need thereof an effective amount of a composition containing a compound of formula (Ia)! ! where R1, R2, R3, R4 and R5 are independently selected from the group consisting of: hydrogen, hydroxy, amino, nitro, iodo, bromo, fluoro, chloro (C1-C6) alkyl , (C1-C6) alkoxy, (C3-C7) cycloalkyl, and phenyl, with at least two of the five R1, R2, R3, R4 and R5 substituents always representing hydrogen, at least one of the five substituents represents a nitro group, at least one of the substituents attached to the nitro group, represents iodine; as well as its pharmaceutically available salts, with
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11465987-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2762111-C1
priorityDate 2005-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415968021
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID468243932
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414230921
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419570574
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457280508
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID807
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394811
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID455695671
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554831
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID87896
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458427722
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID139610
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445794

Total number of triples: 34.